Lin Shinn-Zong,Harn Horng-Jyh,Chiou Tzyy-Wen,Wu Cheng-Han,Yen Ssu-Yin
申请号：
NZ72838614
公开号：
NZ728386A
申请日:
2014.07.04
申请国别(地区):
NZ
年份:
2018
代理人:
摘要：
Disclosed is a use of phthalide compound for the preparation of a medicament. The medicament is especially used for treating and/or delaying the onset of spinal cerebellar atrophy, and the phthalide compound is selected from the following group: butylidene phthalide, a metabolic precursor of butylidene phthalide, a pharmaceutically acceptable salt of the metabolic precursor of butylidene phthalide, a pharmaceutically acceptable ester of the metabolic precursor of butylidene phthalide, and any combination of the foregoing, wherein the metabolic precursor of butylidene phthalide is 3-butylidene-4,5-dihydrophthalide (ligustilide).
